Albert D. Dyrness

Director, Outlook Therapeutics, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 9, 2026Granted 40,789 shares of Hyperliquid Strategies⁴
Dec 2, 2025Returned to company 4,537 shares of Sonnet BioTherapeutics Holdings, Inc.⁵
Dec 2, 2025Other 882 shares of Hyperliquid Strategies⁶
Dec 11, 2023Granted 373 shares of Sonnet BioTherapeutics Holdings, Inc.⁷
Jul 11, 2023Granted 4,000 shares of Sonnet BioTherapeutics Holdings, Inc.⁸
May 30, 2023Bought 23,255 shares at $0.47 of Sonnet BioTherapeutics Holdings, Inc.⁹
Dec 14, 2022Granted 3,770 shares of Sonnet BioTherapeutics Holdings, Inc.¹⁰
Dec 15, 2021Granted 14,152 shares of Sonnet BioTherapeutics Holdings, Inc.¹¹

The numbers on this page point here. Each one links to the record it came from.